Skip to content
Simpler Grants

No. PAR-25-318 · National Institutes of Health

Open

Advancing HIV/AIDS Research within the Mission of the NIDCD (R21 Clinical Trial Optional)

Dealbreakers No cost share required Audit: not stated
Not reimbursement-only
“Grant: A financial assistance mechanism providing money, property, or both to an eligible entity to carry out an approved project or activity.” — From the announcement

At a glance

AI summary

This program funds hypothesis-driven HIV/AIDS research in NIDCD mission areas, including hearing, balance, taste, smell, voice, speech, and language, to improve treatment and prevention for people living with HIV. It supports epidemiological, basic, translational, and clinical research, and for clinical trials it only allows low-risk trials that do not require FDA oversight and are not intended to establish efficacy or change standard of care. Eligible applicants include a wide range of U.S. and foreign organizations, including nonprofits, universities, governments, small businesses, and faith-based or community-based organizations. The combined direct-cost budget for the 2-year project period may not exceed $275,000, with no more than $200,000 in any single year, and the program does not require cost sharing. Foreign organizations and foreign components of U.S. organizations are allowed.

AI-generated summary — verify against the announcement

What it funds

  • Health
  • Research & Discovery
  • Researchers & Scholars
  • Biomedical & Disease Research
Official description from grants.gov

The purpose of this Notice of Funding Opportunity (NOFO) is to stimulate HIV/AIDS research within the scientific mission areas of the National Institute on Deafness and Other Communications Disorders (NIDCD). Applications should address high priority HIV/AIDS research outlined by the NIH Office of AIDS Research (OAR) (https://www.oar.nih.gov/hiv-policy-and-research/research-priorities) in the areas of hearing, balance, taste, smell, voice, speech, and language.For applications proposing a clinical trial, only low risk clinical trials will be supported.

Who can apply

  • City or township governments
  • County governments
  • For-profit organizations other than small businesses
  • Independent school districts
  • Native American tribal governments (Federally recognized)
  • Native American tribal organizations (other than Federally recognized)
  • Nonprofits with 501(c)(3) status (other than higher education)
  • Nonprofits without 501(c)(3) status (other than higher education)
  • Others
  • Private institutions of higher education
  • Public and State controlled institutions of higher education
  • Public housing authorities / Indian housing authorities
  • Small businesses
  • Special district governments
  • State governments
Geographic restriction None found in the announcement — likely nationwide